This event was previously reported to the fda on an alternative summary report (asr approval #: e2013038) which is no longer in effect.Because of additionally received complaint information, this and all further updates will be submitted through the 3500a form.If information is provided in the future, a supplemental report will be issued.
|
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of stress urinary incontinence.It was reported that after implant, the patient experienced pain, recurrence, urinary urgency, frequency and nocturia.Post-operative patient treatment included additional surgeries including implantation of a sling, and small intestine resected and detubularized, used to fashion a cap which was secured to bladder to create new, augmented bladder.
|